Clinical applications by market
Where Getinge Equipment Decisions Meet Local Evidence Rules
Route dental, monitoring, and infection-control reviews by FDA, CE-MDR, UKCA, PMDA, NMPA, and ASEAN documentation expectations.
Clinical applications by market
Route dental, monitoring, and infection-control reviews by FDA, CE-MDR, UKCA, PMDA, NMPA, and ASEAN documentation expectations.
Market tabs
Counts below are planning illustrations for discussion. Confirm actual registrations, authorized representatives, and product availability for the selected reference.
Hospital GPO and IDN reviews typically request 510(k) summaries where applicable, UDI records, IFU revisions, cybersecurity documentation, and service coverage maps. Do not describe 510(k) products as FDA approved.
CE marking under MDR 2017/745 requires configuration-specific declarations, clinical evaluation alignment, PMS plans, and authorized representative details. Language and labeling packages vary by member state.
UKCA and NHS Supply Chain framework reviews focus on intended use, IFU, UK Responsible Person details, and service access across Trust sites.
PMDA pathways and authorized importer arrangements must be confirmed per product family before installation planning or training schedules are finalized.
NMPA registration status, Chinese labeling, and local service capability are verified against the exact catalog number and manufacturing site.
ASEAN markets may require country-level registration, importer licenses, and language packs. Confirm local distributor authority before quoting lead times.
Planning distribution
Use the bars to structure regional coverage conversations. Replace them with your own contract data during RFP response.
Market-specific routing
Share care setting, product family, destination market, and the evidence your value analysis or infection-prevention committee must retain.